Related Experiment Videos
[Sentinel node biopsy in breast cancer: techniques and indications]
Anton Haid1, Michael Knauer, Roswitha Köberle-Wührer
1Abteilung für Allgemein- und Thoraxchirurgie am Landeskrankenhaus Feldkirch, Feldkirch. anton.haid@cable.vol.at
Wiener Klinische Wochenschrift
|April 26, 2005
Summary
Sentinel node biopsy (SNB) is a reliable staging method for breast cancer and melanoma, improving accuracy with advanced techniques. Ongoing trials will confirm its long-term efficacy and impact on patient outcomes.
Area of Science:
- Oncology
- Surgical Pathology
- Nuclear Medicine
Context:
- Sentinel node biopsy (SNB) is established for breast cancer and melanoma staging.
- Its application in other malignancies is under investigation.
- SNB is performed by multidisciplinary teams using radiocolloids and blue dye.
Purpose:
- To evaluate the accuracy and indications of sentinel node biopsy (SNB) in cancer staging.
- To discuss the role of SNB in breast cancer management, including specific tumor sizes and stages.
- To highlight the importance of experienced teams and advanced pathological techniques for accurate staging.
Summary:
- SNB accurately stages lymph nodes in breast cancer and melanoma, enabling focused pathological examination.
- Techniques like serial sectioning and immunohistochemistry improve detection of micrometastases, impacting patient N-stage.
- While safe in specific cases like post-chemotherapy or multicentric breast cancer, its use requires further data; ongoing trials will clarify long-term outcomes.
Impact:
- SNB enhances staging accuracy, potentially reducing the need for extensive axillary dissection and improving patient quality of life.
- The procedure necessitates a collaborative team approach with defined quality indicators.
- Results from large prospective trials are anticipated to provide conclusive evidence on SNB's long-term efficacy and recurrence rates.